Skip to main content

Table 3 Cardiovascular, Fitness and Dietary Health Parameters Before and After the Cardio-Oncology Risk Reduction Program

From: Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy

Variable

Baseline

Follow-up

P Value

Cardiovascular Clinical Evaluation

 Systolic BP/Diastolic BP (mm Hg)

136.7 ± 19.4

124.1 ± 14.0

0.001

 Diastolic Blood Pressure (mm Hg)

84 ± 12.9

78.7 ± 8.2

0.03

 Resting Heart Rate (beats per minute)

81 ± 12.9

86 ± 13.5

0.19

 Body Mass Index (kg/m2)

29.8 ± 9.8

31.5 ± 7.3

0.58

 Body Fat (%)

41.1 ± 5.8

41.3 ± 3.8

0.66

Cardiovascular Laboratory Evaluation

 Total Cholesterol (mg/dL)

183.1 ± 43.6

184.6 ± 45.0

0.40

 HDL Cholesterol (mg/dL)

55.1 ± 16.6

53.7 ± 14.7

0.34

 LDL Cholesterol (mg/dL)

100.6 ± 40.1

104.4 ± 44.9

0.20

 Triglycerides (mg/dL)

137.9 ± 71.6

155.4 ± 105

0.12

 Hemoglobin A1C (%)

7.4 ± 8.3

5.6 ± 0.8

0.11

Physical Fitness Evaluation

 Arm Curl Test (repetitions)

18.5 ± 4.5

21.8 ± 4.7

0.008

 Sit to Stand Test (repetitions)

12.8 ± 2.6

14.5 ± 2.9

0.05

 Trunk Flexion Test (repetitions)

13.6 ± 4.1

12.6 ± 3.2

0.80

Nutrition Evaluation

 REAP Score

26.6 ± 4.7

28.7 ± 4.7

0.007

  1. Values listed as means ± standard deviation; Bold indicates statistical significance; BP blood pressure, REAP Rapid Eating Assessment for Participants